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Filaggrin Deficiency Leads to Impaired Lipid
Profile and Altered Acidification Pathways in a
3D Skin Construct
Katerˇina Va´vrova´1, Dominika Henkes2, Kay Stru¨ver3, Michaela Sochorova´1, Barbora Sˇkolova´1,
Madeleine Y. Witting3, Wolfgang Friess3, Stephan Schreml4, Robert J. Meier5, Monika Scha¨fer-Korting2,
Joachim W. Fluhr6 and Sarah Ku¨chler2
Mutations in the filaggrin (FLG) gene are strongly associated with common dermatological disorders such as
atopic dermatitis. However, the exact underlying pathomechanism is still ambiguous. Here, we investigated the
impact of FLG on skin lipid composition, organization, and skin acidification using a FLG knockdown (FLG )
skin construct. Initially, sodium/hydrogen antiporter (NHE-1) activity was sufficient to maintain the acidic pH (5.5)
of the reconstructed skin. At day 7, the FLG degradation products urocanic (UCA) and pyrrolidone-5-carboxylic
acid (PCA) were significantly decreased in FLG constructs, but the skin surface pH was still physiological owing
to an upregulation of NHE-1. At day 14, secretory phospholipase A2 (sPLA2) IIA, which converts phospholipids to
fatty acids, was significantly more activated in FLG than in FLGþ . Although NHE-1 and sPLA2 were able to
compensate the FLG deficiency, maintain the skin surface pH, and ensured ceramide processing (no differences
detected), an accumulation of free fatty acids (2-fold increase) led to less ordered intercellular lipid lamellae and
higher permeability of the FLG constructs. The interplay of the UCA/PCA and the sPLA2/NHE-1 acidification
pathways of the skin and the impact of FLG insufficiency on skin lipid composition and organization in
reconstructed skin are described.
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INTRODUCTION
Filaggrin (FLG) loss-of-function mutations contribute to several
dermatological disorders such as ichthyosis vulgaris and
atopic dermatitis (AD) (Palmer et al., 2006; Brown and
McLean, 2012). Mutations in the FLG gene are the most
widely occurring genetic risk factors for AD known to date
and have been identified in up to 20–40% of the patients
(Palmer et al., 2006; Jung and Stingl, 2008; O’Regan et al.,
2009). Although FLG mutations are the most common
mutations in these skin disorders, still the overall impact on
the pathogenesis is not fully understood.
FLG is crucial for the adequate development of the
epidermal structure and barrier function (Brown and
McLean, 2012). It is ultimately degraded to its component
amino acids including histidine. These amino acids are highly
hygroscopic and are the major components of the ‘‘natural
moisturizing factor,’’ which is crucial for epidermal hydration
and barrier function (Rawlings and Harding, 2004). Histidine
is of particular importance as it is eventually metabolized to
urocanic acid (UCA) and pyrrolidone-5-carboxylic acid (PCA),
which contribute to the acidification of the stratum corneum
(SC) via the ‘‘histidine-to-UCA/PCA pathway’’ (Krien and
Kermici, 2000; Fluhr and Elias, 2002). Furthermore, because
of the importance of the acidic pH for the formation of the
acidic mantle, other pathways contribute to its formation
(Fluhr et al., 2010). This includes the sodium/hydrogen
antiporter-1 (NHE-1) and the phospholipid (PL)-to-free fatty
acids (FFA) pathways via secreted phospholipases (sPLA2)
(Fluhr and Elias, 2002; Chan and Mauro, 2011). However,
until now the interplay and impact of the single pathways on
the formation of the acidic skin surface pH remain unclear.
The acidic mantle is a prerequisite for the formation of
ceramides (Cer), i.e., the most important lipid class in the SC
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intercellular lipid matrix, and, thus, directly influences the skin
barrier development: In the SC the b-glucocerebrosidase
(GCerase) and acid sphingomyelinase (SMase) metabolize
glycosylceramides (GCer) and sphingomyelin (SM) to Cer.
Both enzymes require an acidic environment of pHp5.5 for
their optimal activity (Feingold, 2007). Thus, a decreased
production of UCA/PCA due to a lack of FLG could result in
an increase of SC pH and, consequently, to a decreased Cer
content. This assumption was underlined by the reduced Cer
levels found in AD patients (Imokawa et al., 1991; Di Nardo
et al., 1998; Bleck et al., 1999; Ishikawa et al., 2010; Park
et al., 2012).
We have previously described a FLG knockdown (FLG )
skin construct, which exhibits disturbed epidermal maturation
and differentiation, increased susceptibility to irritants,
and altered drug absorption (Ku¨chler et al., 2011). In this
study, we investigated how the lack of FLG influences
the composition and organization of the SC lipids generated
in FLG constructs in comparison to normal skin constructs
and isolated human SC and how skin absorption is influenced.
In addition, we determined the amount of UCA/PCA, the
expression of various sPLA2 subtypes, and of the sodium-
hydrogen antiporter NHE-1, sPLA2 activity, and the skin
surface pH in a time-dependent manner to gain deeper
insights in the mechanisms of skin acidification.
RESULTS
FLG constructs contain significantly less UCA and PCA
compared to healthy skin models
The knockdown efficiency of our FLG constructs was
75.7±2.83% (n¼10; Supplementary Figure S5 online). As
expected, FLG knockdown decreased the levels of the
histidine degradation products PCA (FLGþ0.45±0.05
mmol g1 protein; FLG 0.22±0.04mmol g1 protein) and
UCA (FLGþ0.018±0.003mmol g1 protein; FLG 0.011±
0.002mmol g 1 protein) at day 14 (Supplementary Figure S1
online). Similar differences were detected at day 7, but not at
day 4 (Supplementary Figure S4). In comparison to human skin
(UCA 0.210±0.045mmolg1 protein; PCA 2.65±0.42
mmolg1 protein), PCA and UCA levels were reduced.
FLG constructs show significant upregulation of NHE-1 and
sPLA2 IIA
We found a significant upregulation of NHE-1 in the FLG
constructs compared to FLGþ starting at day 7. No significant
differences were seen at day 4 on the mRNA (Figure 1a) and
protein level ( data not shown). sPLA2 IIA was only found
at day 14 in the constructs; its relative expression being
significantly higher in the FLG construct (Figure 1a). The
upregulation of sPLA2 IIA and NHE-1 was further confirmed
on the protein level (Figure 1b and Supplementary Figure S3
online). sPLA2 IB, IIF, V, and XIIA were detected, too, some
of them are only expressed at day 14 and without statisti-
cally significant differences between FLGþ and FLG ,
respectively (Supplementary Figure S2 and Supplementary
Table S1 online). Because of the relatively small difference
in sPLA2 IIA on mRNA level, we also checked for the
activity of the enzyme detecting about 55% increased sPLA2
activity in FLG (36.28±10.70Uml1) compared to FLGþ
(23.38±7.70Uml1).
No differences of skin surface pH were found in FLGþ and FLG
Interestingly, we measured a physiological skin surface pH
around pH 5.5 from day 4 through day 14 of tissue cultivation.
No differences were detected between the FLGþ and
FLG constructs. The respective absolute values are given
in Figure 2 and measurement controls are depicted in
Supplementary Figure S6 online.
FLG knockdown leads to a less ordered skin lipid barrier
The lipid chain order in the SC sheets from normal and FLG
constructs was examined by attentuated total reflectance-
Fourier transform infrared spectroscopy and compared to
hydrated human SC. Cultivated for 7 days, the constructs
displayed more disordered lipid chains than the human SC, as
indicated by the shift of both the methylene symmetric and
asymmetric stretching vibrations towards slightly higher wave-
numbers (over 2,851 and B2,921cm 1, respectively, com-
pared to 2,850 and 2,918cm1 in human SC) and significant
broadening of both bands due to incorporation of more
gauche conformers into the lipid chains (Mendelsohn and
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Figure 1. Sodium/hydrogen antiporter (NHE-1) and secretory phospholipase
A2 (sPLA2) IIA expression. (a) Sodium/hydrogen antiporter (NHE-1) and
secretory phospholipase A2 (sPLA2) IIA expression. Relative mRNA expression
of NHE-1 and sPLA2 IIA in FLGþ (striped bars) and FLG (white bars)
constructs at days 4, 7, and 14, quantified using reverse transcription PCR (RT-
PCR). Mean±SEM, n¼ 10, *Pp0.05. (b) In FLG constructs, the expression
of NHE-1 and sPLA2 IIA at day 14 is clearly increased (green fluorescence). The
nuclei were stained with 40,6-diamidino-2-phenylindole (DAPI) (blue
fluorescence) (bar¼100mm). FLG, filaggrin.
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Moore, 2000); (Figure 3). No differences were found between
FLGþ and FLG cultures at day 7.
In contrast, cultivation for 14 days led to significant differ-
ences between the lipid chain conformations of the constructs.
While the normal cultures showed a trend toward improving
the lipid chain order reflected by lower wavenumbers of
methylene stretching bands and decreased bandwidths, the
opposite was found for FLG . The methylene symmetric
stretching in the FLG construct reached B2,852cm1,
indicating a higher proportion of a liquid ordered phase
(Velkova and Lafleur, 2002) where the lipid chains are still
more ordered than in the fluid phase but display greater lateral
and rotational freedom. This is consistent with the character of
the methylene scissoring mode, which appeared as a single
band at around 1,466cm1, indicating a laterally disordered
phase. The relative amounts of lipids, determined as the
corrected area under the C–H stretching vibration, and also
the lipid/protein ratios, were similar in both models.
FLG constructs contain more FFA compared to normal
constructs
The total lipid content was very similar in both FLG and
FLGþ constructs (approximately 100mgmg1 of dry SC). No
differences were found between the 7 day models con-
sistent with the FTIR results and Mildner et al., (2010).
After a 14 day cultivation of FLGþ constructs, the amounts
of the major barrier lipids FFA (11.3±2.1mg), Chol
(12.5±2.1mg), Cer (21.1±3.7mg), and cholesterol sulfate
(1.3±0.5mg) per mg of SC (Figure 4a) correspond to a roughly
equimolar mixture of FFA, Chol, and Cer, which is in
agreement with previous studies (Wertz, 2000). Yet, the
amount of these barrier lipids was significantly lower in
either construct than in human SC (Figure 4a). In the skin
models, significant amounts of more polar lipid precursors
including SM, GCer, and PL were detected, explaining the
lower lipid chain order of the in vitro constructs compared to
human SC.
In FLG cultivated for 14 days, all these lipid classes
were found, too. The only significant difference between
FLG and FLGþ was an almost 2-fold increase in FFA
(21.9±3.6mgmg1) accompanied by slightly less PL
(22.3±5.8mgmg1) (Figure 4a), suggesting an increased PL
processing into FFA by sPLA2. Importantly, neither glucosyl-
sphingosine (GSph) nor sphingosylphosphorylcholine (SPC),
i.e., the degradation products of SM and GCer found pre-
viously in AD (Hara et al., 2000), was detected.
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Figure 2. Skin surface pH of FLGþ (control) and FLG (FLG knockdown) constructs at day 4, 7, and 14 of tissue cultivation and a histographical analysis of
the spatial surface pH value distributions of the skin constructs using RGB imaging luminescent 2D imaging. Regions of interest are marked with circles, and the
respective mean pH values±SD are given. No differences were observed between FLGþ and FLG at day 4 (n¼ 2), day 7 (n¼4), and day 14 (n¼ 4),
respectively. FLG, filaggrin.
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FLG constructs display similar Cer profiles compared to
FLGþ control
The overall Cer profiles were similar in both in vitro skin
models (Figure 4b). The major Cer species in the skin constructs
were Cer NS and NP (28.8±0.3% and 41.1±2.1%, respec-
tively), which is similar to native human SC, where these
Cer species accounted for 21.3±3.6% and 35.3±4.2%,
respectively. The band below Cer NS was assigned to its
shorter analog (8.7±1.3%, labeled as Cer NS2). Such a
subfraction of Cer NS was not present in human SC but was
detected in reconstructed epidermal models previously (Ponec,
2002; Pappinen et al., 2008). The more polar Cer bands
attributed to hydroxylated Cer AS/NH and Cer AP/AH,
constituted 14.4±2.3% and 2.7±0.6% of the Cer mass
compared to 17.7±2.1% and 16.2±2.7% in human SC,
respectively. The AcylCer species, i.e., EO-type Cer, were
found in some but not all lipid models. The mean levels
were around 1% for either EOS or EOH, which is lower
than in human SC, where they comprised 4 to 5%. Cer
EOP concentrations were below the detection limit. The
highest amounts of Cer EOS and EOH detected were 4.9 and
3.4% with no significant differences between the skin
constructs.
Notably, the percentages of all sphingosine-based Cer
(i.e., CerEOS, NS, NS2, and AS) were slightly lower in the
FLG constructs but without statistical significance.
Skin permeability is increased in FLG for lipophilic agents
We also determined the permeability of the skin constructs.
Testosterone (logP¼3.47) served as lipophilic and caffeine
(logP¼ 0.08) as a hydrophilic model drug. At day 7, neither
for testosterone nor caffeine significant differences in skin
permeability were found in FLGþ and FLG . For testoster-
one, mean apparent permeability coefficients (Papp)±SEM
were 5.01±0.37 106 (FLGþ ) and 5.13±0.31106
cms1 (FLG ). For caffeine, Papp values were 9.33±
0.51 10 6 for FLGþ and 10.03±0.9310 6 cm s1 for
FLG . At day 14, significantly higher skin permeability
was found for testosterone in FLG in our previous work,
whereas no differences were detected for caffeine (Ku¨chler
et al., 2011).
DISCUSSION
The association of FLG mutations with ichthyosis vulgaris and
AD is well established (Brown and McLean, 2012). However,
the exact mechanism leading from genetic defects to clinical
manifestation and the overall impact of these mutations are
still ambiguous (Brown and McLean, 2012). To investigate the
impact of FLG on the skin barrier formation, we developed an
in vitro FLG-deficient skin construct by knocking down its
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Figure 3. Stratum corneum (SC) lipid chain order as indicated by the
wavenumbers of the infrared (IR) methylene symmetric (vs) and asymmetric
(Vas) stretching vibrations (a and c) and their corresponding bandwiths (b and d)
of the hydrated SC samples from normal (FLGþ ) and FLG knockdown
(FLG ) skin models grown for 7 and 14 days compared to isolated human
SC. The hydrated SC samples were examined by attentuated total
reflectance-Fourier transform IR (ATR-FTIR) spectroscopy by coaddition of 256
scans at 4 cm 1 resolution at 23 1C. Mean±SEM, n¼ 8. *Statistically
significant differences compared to human SC or as indicated at Pp0.05.
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Figure 4. The stratum corneum (SC) (a) lipid content and (b) ceramide (Cer)
profiles in FLGþ and FLG reconstructed skin grown for 14 days compared
to human SC. The analyses were performed on silica gel 60 high-performance
thin-layer chromatography (HPTLC) plates and quantitated by densitometry
after dipping in 7.5% CuSO4, 8% H3PO4, and 10% MeOH in water for
10 seconds and heating at 160 1C for 30minutes. Free fatty acids (FFA), and
cholesterol (Chol) were separated using chloroform/methanol/acetic acid
190:9:1.5 (v/v/v) twice to the top of the plate. The other lipids were separated
using chloroform/methanol/acetic acid/water 65:25:6:3 (v/v/v). Mean±SEM,
n417. *Indicates statistically significant differences compared to human SC at
Pp0.05.þStatistically significant differences between FLGþ and FLG skin
models at Pp0.05. AS, a-hydroxy sphingosine; CholS, cholesterol sulfate; EOS,
ceramide 1; FLG, filaggrin; GCer, glucosylceramide; NP, phytoceramide; NS,
non-hydroxy sphingosine; PL, phospholipid.
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expression in primary, human keratinocytes using small
interfering RNA (Ku¨chler et al., 2011). In this study, we
elucidated the influence of FLG on the skin lipid formation
and composition and the acidification mechanism in FLG-
deficient constructs in a time-dependent manner. The
advantage of in vitro FLG knockdown constructs is that we
are able to investigate the influence of FLG alone without
other possibly contributing factors.
In terms of skin lipid organization, we found less ordered
intercellular lipid lamellae in FLG constructs compared
to the normal constructs at day 14, indicating a decreased
viscosity and higher degree of freedom of mobility of the lipid
chains. A similar decrease in lipid chain order was found in
non-lesional SC from patients with AD and psoriasis (Wohlrab
et al., 2001). This disorder was accompanied by a significantly
higher permeability for lipophilic drugs in FLG skin
constructs at day 14 (Ku¨chler et al., 2011), which is in
agreement with (Potts and Francoeur, 1990). These results
correspond well with the observed changes in sPLA activity
(upregulation at day 14), fatty acid level (increase at day 14),
and skin lipid order (decreased at day 14) in FLG . In
contrast, no differences in permeability were found at day 7.
When considering the lipid chain packing, electron diffrac-
tion showed a higher proportion of hexagonal compared to
orthorhombic lateral chain packing in AD patients (Pilgram
et al., 2001). However, we were unable to confirm this finding
as our in vitro constructs generally did not form the
orthorhombic lipid lattice. This is well in accordance with
findings from other skin constructs (Thakoersing et al., 2012).
First, we assumed that the changes in the lipid chain order
must be related to a decrease in Cer levels in the FLG
constructs. Such a lack of Cer was described repeatedly in AD
patients (Di Nardo et al., 1998; Bleck et al., 1999; Imokawa,
2009; Ishikawa et al., 2010). The lack of FLG and, thus, the
impairment of the UCA/PCA acidification pathway may affect
the activity of the Cer-generating enzymes GCerase and
SMase that need an acidic pH (Fluhr and Elias, 2002). On
the other hand, comparable Cer levels in AD and healthy skin
were also found in vivo (Farwanah et al., 2005). Although our
lipid analyses showed lower levels of Cer in the FLG
constructs, this was neither statistically significant nor
consistently found in the individual tissues. Therefore, there
must be additional mechanism independent of FLG mutations
leading to Cer deficiency. This is in agreement with recent
reports (Jakasa et al., 2011; Janssens et al., 2011). The ability
to generate Cer from their precursors can be explained by
increased sPLA2 and/or NHE-1 activity, which acidify the SC
in the absence of UCA/PCA and, thus, ensure the activity of
GCerase and SMase (Fluhr et al., 2010).
The Cer profiles were similar in both constructs; we only
found a slight decrease in total sphingosine-based Cer in
FLG compared to with FLGþ . This seems to be contra-
dictory to the lower abundances in Cer NP and total Cer EO in
AD patients (Janssens et al., 2011). However, in that
study, patients with the most prevalent FLG mutations were
excluded, suggesting that those changes were FLG indepen-
dent. Unfortunately, only some of our constructs contained
detectable amounts of the EO-type Cer; thus, we could not
study whether FLG knockdown contributes to the decrease of
these extremely long acylCer found previously in AD (Park
et al., 2012). Notably, neither GSph nor SPC were detected in
the skin constructs. These lysolipids are formed from GCer and
SM, respectively, by the action of GCer-SM-deacylase, which
is highly expressed in the skin of AD patients. The breakdown
of these Cer precursors leads to Cer deficiency and barrier
disruption (Hara et al., 2000; Ishibashi et al., 2003). Our data
suggest that there is no link between FLG and GCer-SM-
deacylase in AD, both can independently contribute to skin
lipid barrier abnormalities.
The most striking feature in the SC lipid profiles of our skin
constructs was the almost 2-fold increase of the FFA fraction in
FLG compared to FLGþ at day 14 strongly suggesting
an involvement of sPLA2 as an alternative acidification
pathway. Indeed, at day 14 we observed a significant increase
of sPLA2 IIA in FLG constructs and an about 55% increased
sPLA2 activity explaining the high amounts of FFA. This is in
line with previous in vivo findings: two times higher FFA
levels were found in atopic epidermis (1.30±0.74mgg 1
wet weight) compared to healthy epidermis (0.61±
0.14mgg1) (Scha¨fer and Kragballe, 1991). Furthermore,
Tarroux et al. (2002) found significantly increased sPLA
activity in atopic skin and a decrease in activity upon
treatment. The increased production of FFA because of
sPLA2 IIA upregulation not only disturbs the lipid ratio and
lipid order in the skin barrier but also directly contributes to
inflammatory processes (Chan and Mauro, 2011).
Because these changes were detected only at day 14, we
further investigated the time course of the pH values of the
skin constructs. Interestingly, we found a physiological pH of
about 5.5 from day 4 through day 14 of tissue cultivation in
both constructs, suggesting that other mechanisms than FLG
maintain the SC acidity in the absence of FLG. Initially, at day
4, the basal activity of NHE-1 is fully sufficient to maintain the
acidic pH. This idea is substantiated by the high abundance of
NHE-1 in the skin constructs already at day 4. This result is in
good agreement with previous findings that FLG-UCA/PCA
pathway is not essential for SC acidification (Fluhr et al., 2010)
and that NHE-1 is the primary source of acidic microdomains
activating lipid processing enzymes (Behne et al., 2002).
At day 7, the lack of FLG becomes apparent as UCA/PCA
values are significantly lower in FLG constructs (Supple-
mentary Figure S4 online). NHE-1 is still able to maintain an
acidic pH but is significantly upregulated in FLG , which is
likely a compensatory mechanism of the decreased UCA/PCA-
based acidity. At this time point, FLGþ and FLG constructs
are still very similar as also indicated by the skin lipid
arrangement and permeability being in a good agreement
with (Mildner et al., 2010), who cultivated their models for
7 days. The most pronounced consequences of FLG deficiency
appear at later time points because of the progressive
differentiation and maturation of the skin constructs. At day
14, NHE-1 is still upregulated in FLG constructs but yet
another acidification mechanism is activated: the PL-FFA
conversion by sPLA2. The importance of NHE-1 and sPLA2
for skin acidification has been demonstrated before (Fluhr
et al., 2001, 2004). While this happens in both FLG and
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FLGþ constructs, the expression and activity of sPLA2 are
significantly higher in the FLG . Thus, although the time
course of NHE-1- and FFA-based acidification pattern of the
skin constructs is not affected by deficient FLG, these two
pathways are upregulated to compensate for the lack of FLG-
His-UCA/PCA.
The question is what exactly is the trigger activating the
other acidification pathways. As we did not detect any
differences in pH between FLGþ and FLG , it seems that
these compensatory mechanisms are activated by very small
or localized pH changes that we are not able to measure.
Another possibility is that acidification is controlled not by pH
itself but by the levels of products or intermediates of other
acidification pathways. The latter possibility would be more
advantageous as it would prevent pH changes rather than
correct them.
Nevertheless, we cannot exclude that there are other key
players involved in the acidification process that have not yet
been identified as also suggested by Behne et al. (2002). Our
findings are well in line with Fluhr et al. (2010) and
substantiate the idea of compensatory mechanism between
different pathways to ensure skin acidification.
In conclusion, the decreased levels of UCA/PCA accom-
panied by an increase of NHE-1 and later sPLA2 IIA in FLG
constructs demonstrate an interplay between different skin
acidification pathways. Figure 5 displays the suggested pro-
cesses of skin acidification. In addition, using in vitro skin
constructs, we showed that FLG deficiency directly influences
the skin lipid orientation by increasing the amount of FFA and,
thus, affecting skin permeability. Our results considerably
contribute to the understanding of skin acidification and the
impact of FLG deficiency on skin barrier dysfunction. To our
best knowledge, these direct interdependencies have not been
described before.
MATERIALS AND METHODS
Cer NS and AS, GCer, SM, GSph, and SPC were purchased from
Avanti Polar Lipids (Alabaster, AL). Cer NP was prepared by acylation
of phytosphingosine with lignoceric acid as described previously
(Novotny et al., 2009a, 2009b). The structure and purity of the
prepared Cer NP were confirmed by 1H and 13C nuclear magnetic
resonance spectra (Varian, Palo Alto, CA, Mercury-Vx BB 300
instrument, operating at 300MHz for 1H, 75MHz for 13C), MS
(Agilent 500 Ion Trap LC/MS, Santa Clara, CA), and infrared spectra
(Nicolet 6700 FTIR spectrophotometer, Thermo Scientific, Waltham,
MA). Chol and all other chemicals were from Sigma-Aldrich
(Schnelldorf, Germany). Radiolabeled 1,2,6,7-3H-testosterone was
from Amersham (Freiburg, Germany). Radiolabeled 1-methyl-14C-
caffeine was from Arc (St Louis, MO).
Preparation of skin constructs
The skin constructs (FLGþ and FLG ) have been generated
according to Eckl et al. (2011) and Ku¨chler et al. (2011). SC was
isolated after 4, 7, and 14 days. The constructs were placed on a filter
paper soaked in 0.5% trypsin in phosphate-buffered saline (PBS, pH
7.4) (Kligman and Christophers, 1963). The isolated SC sheets were
washed with PBS and any remaining keratinocytes were removed
with a cotton swab. Subsequently, SC sheets were washed
with acetone to remove surface contaminants, vacuum-dried, and
stored at  20 1C. Isolated human SC served as control.
FTIR spectroscopy
IR spectra of the samples were collected on a Nicolet 6700 FTIR
spectrometer (Thermo Scientific) equipped with a single-reflection
MIRacle attenuated total reflectance germanium crystal at 23 1C.
The spectra were generated by coaddition of 256 scans collected
at 4 cm 1 resolution and analyzed with the Bruker OPUS
software (Bruker Corp, Billerica, MA). The exact peak positions were
determined from second derivative spectra and by peak fitting if
needed.
Isolation of SC lipids
For the extraction of the SC intercellular lipids, a modified (Bligh and
Dyer, 1959) method was used. The SC samples were extracted with
1ml CHCl3/MeOH 2:1 (v/v) per mg of SC for 1.5hours, filtered,
separated, and concentrated under a stream of nitrogen. The lipids
were dried and stored at  20 1C under argon.
High-performance thin-layer chromatography lipid analysis
The lipid analysis was performed on silica gel 60 high-performance
thin-layer chromatography plates (20 10cm2; Merck, Darmstadt,
Germany). The extracted SC lipids were dissolved in 100ml CHCl3/
MeOH 2:1. Ten microliters of each lipid sample was sprayed on
the plate using a Linomat IV (Camag, Muttenz, Switzerland). Standard
lipids were dissolved in CHCl3/MeOH 2:1 (v/v) (Cer NS, AS, NP,
Chol, and palmitic acid), CHCl3/MeOH 1:1 (v/v) (CholS, GCer, and
SM), and MeOH GSph and SPC), respectively, at 1mgml 1.
They were first analyzed separately during method development
and then mixed at 50mgml 1 and applied on an high-perfor-
mance thin-layer chromatography plate together with the
analyzed samples to generate calibration curves from 50ng to
7.5mg. The major skin barrier lipids (Cer, FFA, and Chol) were
separated using CHCl3/MeOH/acetic acid 190:9:1.5 (v/v/v) mobile
phase two times to the top of the plate (Bleck et al., 1999).
The Cer precursors (GCer and SM), their degradation products
(GSph and SPC), and CholS were separated using a more polar
mobile phase (CHCl3/MeOH/acetic acid/H2O 65:25:6:3 (v/v/v)).
FLG His
sPLA2
PL FFA
Serine
proteases
Cohesion
Desquamation
Antimicrobial peptides
GCerase
SMase
Stratum corneum
lipid barrier
UCA/PCA
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Proton pump
antiporter NHE-1
pH
Figure 5. Stratum corneum pH unifying concept. In filaggrin (FLG) deficiency,
sodium/hydrogen antiporter (NHE-1) and secretory phospholipase A2 (sPLA2)
are upregulated to maintain the acidic pH needed for a variety of skin
functions. Adapted and modified from Fluhr et al. (2002). Cer, ceramide; FFA,
free fatty acid; GCerase, b-glucocerebrosidase; His, histidine; NHE-1, sodium/
hydrogen antiporter; PCA, pyrrolidone-5-carboxylic acid; SMase,
sphingomyelinase; UCA, urocanic acid.
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The lipids were visualized by dipping in a derivatization reagent
(7.5% CuSO4, 8% H3PO4, and 10% MeOH in water) for 10 seconds
and heating at 160 1C for 30minutes and quantitated by densitometry
using TLC scanner 3 and WinCats software (Camag, Muttenz,
Switzerland).
Determination of FLG, sPLA2, and NHE-1 expression
For isolation of RNA, the constructs were harvested at day 14 and
punched to discs (10mm). Epidermis was frozen using liquid nitrogen
and then milled for 30 seconds at 25Hz using a TissueLyzer (Qiagen,
Hilden, Germany). Subsequently, RNA was isolated using Nucleo
Spin RNA II according to the manufacturer’s instruction. For cDNA
synthesis, RevertAid First Strand cDNA Synthesis Kit (Thermo Scientific)
was used according to the manufacturer’s instruction.
For relative quantification of FLG, NHE-1, and sPLA2 isoforms’
expression, reverse transcription PCR was performed using the SYBR
Green I Masterplus kit (Roche, Penzberg, Germany). For primer
sequences see Supplementary Table S2 online. The housekeeping
gene YWHAZ served as control.
Skin surface pH measurements
Luminescent 2D imaging of pH (Meier et al., 2011; Schreml et al.,
2011) was performed via RGB imaging (Meier et al., 2011) of pH
sensor foils consisting of a hydrogel layer containing pH indicator
microparticles (FITC bound to aminoethylcellulose) and reference
particles (ruthenium(II)-tris(4,7-diphenyl-1,10-phenanthroline) incor-
porated in polyacrylonitrile). Sensor foils were gently applied to the
3D skin construct surfaces and were allowed to slowly adapt by
adhesion forces. Calculations and pseudocolor image processing
were carried out with ImageX software (Microsoft Corporation,
Redmond, WA) and ImageJ (http://rsbweb.nih.gov/ij/). For details see
Supplementary methods online.
Immunohistochemistry
After 14 days, the constructs were embedded in tissue freezing
medium (Leica Microsystems, Nussloch, Germany) and frozen using
liquid nitrogen. After overnight storage at  80 1C, the constructs
were cut to vertical slices (5mm) with a freeze microtome (Leica
Microsystems, Nussloch, Germany). After fixation, they were washed
with PBS containing 1% BSA and blocked with normal goat serum
(1:20 in PBS). The sections were incubated for 1 hour with primary
rabbit antibodies specific against NHE-1 and sPLA2 IIA (Abcam,
Cambridge, UK) diluted in PBS containing 1% BSA (1:400 and 1:200,
respectively) and subsequently with goat-anti-rabbit IgG DyLight 488
antibody (Dianova, Hamburg, Germany). After washing, the sections
were embedded in antifading mounting medium (Dianova) and
analyzed with a fluorescence microscope (BZ-8000; Keyence,
Neu-Isenburg, Germany).
Skin permeability testing
The skin permeability was evaluated according to validated test
procedures (Scha¨fer-Korting et al., 2008). Briefly, stock solutions of
testosterone (40mgml 1, 2% (v/v) Igepal CA-630) and caffeine
(1mgml 1) were spiked with an appropriate amount of the
radiolabelled compound to achieve a total radioactivity of
2mCiml 1. Permeation studies were performed at day 7 using a
static setup (Franz-type diffusion cells, diameter 15mm, volume 12ml;
Permegear, Bethlehem, PA).
Statistical analysis
Wilcoxon’s signed-rank test or t-test were used when comparing two
different conditions according to the results of D’Agostino–Pearson
normality test. When comparing three or more conditions, a one-way
analysis of variance with a Bonferroni post hoc test or Friedman plus
Dunn’s tests was performed using SigmaStat for Windows 3.5 (SPSS,
Chicago, IL). Pp0.05 was considered significant. The data are
presented as means±SEM.
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